Zydus Wellness enters FY27 harvest phase as ₹7,800-cr acquisition bet faces execution test
FY26 sales jumped 46% to ₹3,940 cr after Comfort Click buyout, with EBITDA up 34% to ₹510 cr. FY27 guidance points to ₹5,700 cr revenue and 17-18% margins, but integration of UK D2C portfolio, Complan turnaround and ₹2,800-3,000 cr debt reduction remain the swing factors.
What happened
Zydus Wellness posted FY26 sales of ₹3,940 cr (+46%) and enters FY27 as a harvest year for its ₹7,800 cr acquisition spree, focusing on Comfort Click
Key facts
- FY26 net sales ₹3,940 cr (+46.4%)
- FY26 EBITDA ₹510 cr (+34.2%)
- FY26 PAT ₹197 cr
- FY27E revenue ₹5,700 cr (+44.7%)
- EBITDA margin target 17-18%
- Acquisitions ₹7,800 cr total
- Gross margin 60.2% in FY26
- Sugar Free 96.1% share
- Glucon-D 58.9% share
- Q-comm 7-8% of domestic revenue
- E-comm 17% of domestic
- Debt ₹2,800-3,000 cr
Why this matters
Zydus is signalling that the ₹7,800-cr Comfort Click deal moves it from sugar-substitute pure-play to a diversified wellness platform, opening comparable D2C bolt-on M&A theses across Indian consumer health.